Chronic infection with HBV is a major risk factor in the development of hepatocellular carcinoma (HCC), and is responsible for over 1 million deaths each year. We have established an HCC cofactor role in transgenic mice that express the HBV regulatory protein (HBx) driven by the human alpha-l-anti-trypsin regulatory sequences (ATX mice). Our recent studies indicate that the cofactor role involves the ability of HBx to deregulate hepatocyte cell cycle controls. Although HBx is essential for virus replication in vivo, the function that it provides is not known. We hypothesize that the essential role of HBx during viral replication is to prepare hepatocytes to become competent to support all steps in virus replication. In the present application, we will explore the effects of HBx on G0 hepatocytes and their transition through early G1, using markers that distinguish these stages of the cell cycle. We additionally hypothesize that HBx holds nondividing cells at a G1 restriction point, and will use RNA inhibition to examine candidate proteins through which HBx may exert this effect. We will also explore the effect of HBx on hepatocyte G0/G1 transition in vivo, and in the presence of the AFBl-induced hotspot p53 mutation. Finally, the livers of ATX mice contain decreased levels of Caspase-3, and we will test the hypothesis that in response to cytotoxic cytokines, HBx inhibits apoptosis as a means of protecting hepatocytes from immune-mediated cell death. HBx is the sole regulatory protein encoded by HBV, we expect it will provide more than one critical role during the virus life cycle. The proposed program builds on our model of HBx-related HCC that indicates an important contribution of HBx effects on cell cycle control. The planned studies examine HBx function in nondividing liver cells, and the results obtained will provide important insight into the rational development of new therapies to treat chronic HBV infection. Our results will also reveal fundamental virus-host interactions that may extend to other viruses that replicate in the liver.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA095388-03
Application #
6928570
Study Section
Special Emphasis Panel (ZRG1-EVR (02))
Program Officer
Read-Connole, Elizabeth Lee
Project Start
2003-07-01
Project End
2008-06-30
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
3
Fiscal Year
2005
Total Cost
$301,376
Indirect Cost
Name
Baylor College of Medicine
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Slagle, Betty L; Andrisani, Ourania M; Bouchard, Michael J et al. (2015) Technical standards for hepatitis B virus X protein (HBx) research. Hepatology 61:1416-24
Hodgson, Amanda J; Hyser, Joseph M; Keasler, Victor V et al. (2012) Hepatitis B virus regulatory HBx protein binding to DDB1 is required but is not sufficient for maximal HBV replication. Virology 426:73-82
Kumar, Manish; Jung, Sung Yun; Hodgson, Amanda J et al. (2011) Hepatitis B virus regulatory HBx protein binds to adaptor protein IPS-1 and inhibits the activation of beta interferon. J Virol 85:987-95
Keasler, Victor V; Hodgson, Amanda J; Madden, Charles R et al. (2009) Hepatitis B virus HBx protein localized to the nucleus restores HBx-deficient virus replication in HepG2 cells and in vivo in hydrodynamically-injected mice. Virology 390:122-9
Longato, Lisa; de la Monte, Suzanne; Kuzushita, Noriyoshi et al. (2009) Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver. Hepatology 49:1935-43
Hodgson, Amanda J; Keasler, Victor V; Slagle, Betty L (2008) Premature cell cycle entry induced by hepatitis B virus regulatory HBx protein during compensatory liver regeneration. Cancer Res 68:10341-8
Keasler, Victor V; Hodgson, Amanda J; Madden, Charles R et al. (2007) Enhancement of hepatitis B virus replication by the regulatory X protein in vitro and in vivo. J Virol 81:2656-62
Keasler, Victor V; Lerat, Herve; Madden, Charles R et al. (2006) Increased liver pathology in hepatitis C virus transgenic mice expressing the hepatitis B virus X protein. Virology 347:466-75